Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma (Q43461206)

From Wikidata
Jump to navigation Jump to search
scientific article published on 21 August 2012
edit
Language Label Description Also known as
English
Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma
scientific article published on 21 August 2012

    Statements

    Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma (English)
    Alexander B Stillebroer
    Ingrid M E Desar
    Marije J Boers-Sonderen
    Carla M L van Herpen
    Johannes F Langenhuijsen
    Peter M Smith-Jones
    Egbert Oosterwijk
    Peter F A Mulders

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit